City
Epaper

COVID-19: Bharat Biotech urges healthcare workers to ensure administration of only Covaxin to 15-18 years agegroup

By ANI | Published: January 08, 2022 2:02 AM

Hyderabad-based vaccine manufacturer Bharat Biotech on Friday said that it has received reports of COVID-19 vaccines other than Covaxin are being administered in children of age group 15-18 years in the country and urged healthcare workers to ensure administration of Covaxin as it is the only approved COVID vaccine for this particular population category.

Open in App

Hyderabad-based vaccine manufacturer Bharat Biotech on Friday said that it has received reports of COVID-19 vaccines other than Covaxin are being administered in children of age group 15-18 years in the country and urged healthcare workers to ensure administration of Covaxin as it is the only approved COVID vaccine for this particular population category.

"We have received several reports of other COVID-19 vaccines being administered to individuals in the 15-18 years age group. We humbly request healthcare workers to be highly vigilant and ensure that only Covaxin is administered to individuals in the 15-18 years age group," read a Bharat Biotech release.

"Covaxin received approval based on a thorough clinical trial evaluation for safety and immunogenicity in the 2-18 years age group. Currently, it is the only COVID-19 vaccine in India approved for children," it added.

COVID vaccination program for children aged between 15 and 18 years has been started from January 3, 2022.

The Union Health Ministry has informed the States and UTs that only 'Covaxin' is to be administered in this population category and additional doses of 'Covaxin' will be sent to all states and UTs.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Bharat Biotech InternationalUnion Health Ministry
Open in App

Related Stories

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

HealthDoctors who scored zero can now study PG medical courses

InternationalSaudi Arabia says health plans for Haj season successful

NationalYoga gaining popularity across the world: Mansukh Mandaviya

NationalMansukh Mandaviya to review heatwave preparedness with affected states today

National Realted Stories

NationalBJP welcomes Exit Poll findings, RJD questions their relevance

NationalExit Polls prove political pundits wrong in Karnataka: State BJP chief

NationalCurtains come down on Lok Sabha polls with over 61 per cent turnout in final phase

NationalMahaYuti to lose some, MVA to gain few, predicts Marathi channel Exit Poll

NationalCounting of votes polled in Arunachal, Sikkim Assembly elections on Sunday